The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Good thanks Gige, how about you?
Gyrometric is a quality company
Huge thank you to Nigel for stepping in to assist shareholders in removing the corrupt, self serving incumbents and then putting measures in place to assist with the turnaround of the company and provide the firm foundations for the current growth phase. It was a particularly tough period when the new board took over and their experience and endeavour was invaluable. I know Nigel is happy to hold his shares safe in the knowledge the company is in safe hands with Paul Brenton in charge and looks forward to seeing the share price reach its true potential being many multiples of the current level.
Yes, you are correct trout
Utter rubbish. There is no book build that I am aware of.
With the interims. Turnaround underway but we are merely at the foothills of the recovery. I am as certain as I can be that the share will be trading considerably higher in the coming weeks as we welcome new investors both private and quite possibly corporate. A note of thanks to NB, TB and JZ for stepping in to the benefit of shareholders at a time of great difficulty. They can all be immensely proud of their achievements that have put MRS on track for great things
Morning, I voted against it but quite simply not enough people voted. Think about a third of shares in issue were cast. To be frank I just cant see any point in him being there and we could save the salary, plus he was part of the old guard that took the company to the brink. Still it is what it is. Maybe they can find a use for him to justify his salary.
Myself and several other PI's attended the AGM yesterday. The main takeaway for me was the very bullish mood from the BOD. They seem genuinely excited by the prospects at MRS over the coming weeks, months and years. It is no secret that the board inherited an administrative shambles from the previous team who quite frankly should never be let near a listed company again. The main priority upon arrival was steadying the ship and getting the business to the point that management accounts could be produced correctly and on time. As evidenced by the annual results and the most recent update phase one of the job is now complete and we are now in the growth phase. I would expect to see more regular updates on the business including contract wins and regular trading updates coupled with a greater presence on social media. The point was made that many MRS employees and also MRS customers were only just returning from the christmas break so i would expect to see some further update shortly. I feel that the EPS predictions have probably been underplayed and that these will be upgraded as the year progresses. I also feel that the current SP leaves the company open for an approach. Once the interims are out hopefully confirming continued progress this may assist any corporate capital or possible suitor in their decision process. Added more yesterday on the dip. DYOR etc. GL
Well done to the new board for starting to make the business what we all thought it could be. Buy and hold as not even started yet.
Trade was my isa transfer. Took that in the placing with a target of .2 over the next couple of months. Think the existing investments will be sold down over time.
Happy New Year to you too. I did sell out a while back. I tend to find that buying shares and selling them for a profit is the best approach rather than holding on for a loss. I am considering a re-entry here as the risk reward is favourable again imv but no position currently. Good luck with your investments.
Good to see the stakes in the strategic investments increasing. The proposed raise for Kirkstall gives a flavour of the potential value, but that is still very early stage. I expect in the fullness of time each of the strategic investments to be worth over �20m before realisation. We should see regular newsflow on each of the strategic investments to keep investors interested The fund management business ticks over nicely and pays for the corporation costs. The overheads are reducing and the non core investments will be realised at a time when they can offer the best return. added a few more today on the drop and happy to increase further.
Nice update indeed this morning. More progress made.
and in the case of BRH TB took over as CEO on 24th August 2015 then the share price was just over 7p.
in fairness TB quit the AVO board in August 2013.
Agree. Going to stick my neck out and say that I think we will see double figures here this year.
Extremely high hopes for this share. TB is a master at finding niches within the medical world. He also runs a very tight ship, cutting costs to the bone and preserving shareholder funds. He always has a large amount of skin in the game too. How many companies with a market cap of £1.5m have a product which can be sold globally and offers near term revenue?
Yes, been loading up here whilst it is quiet. Cash supporting the MC and about time for a deal to be done